Literature DB >> 8931574

Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2.

A Dürr1, C S Davoine, C Paternotte, J von Fellenberg, S Cogilinicean, P Coutinho, C Lamy, S Bourgeois, J F Prud'homme, C Penet, J L Mas, J M Burgunder, J Hazan, J Weissenbach, A Brice, B Fontaine.   

Abstract

We report the clinical features of 12 families with autosomal dominant spastic paraplegia (ADSP) linked to the SPG4 locus on chromosome 2p, the major locus for this disorder that accounts for approximately 40% of the families. Among 93 gene carriers, 32 (34%) were unaware of symptoms but were clinically affected. Haplotype reconstruction showed that 90% of the asymptomatic gene carriers presented increased reflexes and/or extensor plantar responses independent of age at examination. The mean age at onset was 29 years, ranging from 1 to 63 years. Intra- as well as inter-familial variability of age at onset was important, but did not result from anticipation. Phenotype-genotype correlations and comparison with SPG3 and SPG5 families indicated that despite the variability of age at onset, SPG4 is a single genetic entity but no clinical features distinguish individual SPG4 patients from those with SPG3 or SPG5 mutations.

Entities:  

Mesh:

Year:  1996        PMID: 8931574     DOI: 10.1093/brain/119.5.1487

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  12 in total

1.  A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34.

Authors:  B Fontaine; C S Davoine; A Dürr; C Paternotte; I Feki; J Weissenbach; J Hazan; A Brice
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 2.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

3.  A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity.

Authors:  E Reid; A M Dearlove; M Rhodes; D C Rubinsztein
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

4.  A locus for autosomal dominant "pure" hereditary spastic paraplegia maps to chromosome 19q13.

Authors:  E Reid; A M Dearlove; O Osborn; M T Rogers; D C Rubinsztein
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

5.  Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family.

Authors:  Shiroh Miura; Hiroki Shibata; Hiroshi Kida; Kazuhito Noda; Takayuki Toyama; Naoka Iwasaki; Akiko Iwaki; Mitsuyoshi Ayabe; Hisamichi Aizawa; Takayuki Taniwaki; Yasuyuki Fukumaki
Journal:  Neurogenetics       Date:  2010-09-22       Impact factor: 2.660

6.  Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p.

Authors:  O Heinzlef; C Paternotte; F Mahieux; J F Prud'homme; J Dien; M Madigand; J Pouget; J Weissenbach; E Roullet; J Hazan
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

7.  Genetic and chemical modulation of spastin-dependent axon outgrowth in zebrafish embryos indicates a role for impaired microtubule dynamics in hereditary spastic paraplegia.

Authors:  Richard Butler; Jonathan D Wood; Jennifer A Landers; Vincent T Cunliffe
Journal:  Dis Model Mech       Date:  2010-09-09       Impact factor: 5.758

Review 8.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

Review 9.  Hereditary spastic paraplegia.

Authors:  John K Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

10.  Urodynamic evaluation of patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24.

Authors:  L N Jensen; T Gerstenberg; E B Kallestrup; P Koefoed; J Nordling; J E Nielsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.